Start here if you're new
what it is
Avient makes plastic compounds, colorants, and additives that end up in pipes, floors, bottles, wires, and appliance parts.
how it gets paid
Last year Avient made $3.3B in revenue. Thermoplastic compounds was the main engine at $1.12B, or 34% of sales.
why it's growing
Revenue grew 0.6% last year. Demand from the healthcare, defense, and telecom markets should have remained firm, but weak in the consumer packaging, and energy arenas.
what just happened
The latest read was messy: EPS came in at $0.18 versus a $0.54 estimate, even as reported Q4 revenue reached $761M.
At a glance
B+ balance sheet — decent shape, but not bulletproof
20/100 earnings predictability — expect surprises
31.2x trailing p/e — you're paying up for this one
2.9% dividend yield — cash in your pocket every quarter
5.5% return on capital — nothing to write home about
xvary composite: 47/100 — below average
What they do
Avient makes plastic compounds, colorants, and additives that end up in pipes, floors, bottles, wires, and appliance parts.
Avient sells into boring products you use every day, and boring is the point. It distributes resins to 20 of the largest plastic producers, and 62% of 2024 sales came from outside the U.S. Custom formulations (specialized compounds → plastic recipes built for a job → switching can disrupt your product line) keep customers around.
How they make money
$3.3B
annual revenue · their business grew +0.6% last year
Thermoplastic compounds
$1.12B
Colorants and additives
$0.84B
PVC and vinyl solutions
$0.56B
Wire and cable materials
$0.43B
Resin distribution and other
$0.35B
The products that matter
formulates additives and colorants
specialty polymer materials
$3.3B revenue · +0.6% growth
it is the whole $3.3B business, and that barely moved last year. with only a 5.0% net margin, a small shift in mix or pricing has an outsized effect on profit.
entire business
Key numbers
$2.0B
long-term debt
Debt equals 35% of capital, so your upside depends on profit gains outrunning balance-sheet drag.
31.2x
trailing p/e
You are paying a premium multiple for a business with past sales down 2.5% a year and return on capital at 5.5%.
62%
international sales
Most revenue comes from outside the U.S., which gives reach but also adds currency and trade-policy risk.
12.5%
operating margin
Operating margin means profit before interest and taxes → core business earnings → this is the cushion against raw-material swings.
Financial health
B+
strength
- balance sheet grade B+ — solid but not elite
- risk rank 3 — safer than 50% of stocks
- price stability 50 / 100
- long-term debt $2.0B (35% of capital)
- net profit margin 5.6% — keeps 6 cents of every dollar in revenue
- return on equity 8% — $0.08 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in AVNT 3 years ago → it's now worth $11,040.
The index would have given you $13,880.
source: institutional data · total return
What just happened
missed estimates
The latest read was messy: EPS came in at $0.18 versus a $0.54 estimate, even as reported Q4 revenue reached $761M.
That gap tells you the issue is not just sales. Profit conversion is the problem. Gross margin was 31.4%, but trailing EPS is still only $1.09.
$761M
revenue
$0.71
eps
31.4%
gross margin
the number that mattered
The $0.18 vs $0.54 miss mattered most because it says margin repair is still weaker than the market expected.
-
avient is endeavoring to use its capital more wisely.over the past 10 years, shareholders’ equity has more than tripled, but profits, albeit being erratic, haven’t increased.
-
as a result, return on equity has dwindled.this is because avient has been operating more as a commodity polymer maker, rather than a specialty one. avient has thus been offloading some commodity operations and buying more specialty polymer units, specifically in the higher margin defense, healthcare (medical supply), and fastgrowing packaging and industrial sectors.
-
it’s also investing in making chemicals that will serve the ai and electrification arenas.this is all in the hopes of getting earnings, sales, and thus the stock price, moving up in a more consistent fashion.
-
stock growth consistency hasn’t been the company’s strong suit.meanwhile, we look for fourth-quarter 2025 sales and share earnings of $745 million and $0.54, respectively.
-
these numbers are a result of a continuation of third-quarter business trends.demand from the healthcare, defense, and telecom markets should have remained firm, but weak in the consumer packaging, and energy arenas.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is tariffs and trade friction across a global specialty polymer supply chain.
med
trade policy can hit both cost and demand
avient sells into a global manufacturing chain. if tariffs or cross-border restrictions tighten, you are not talking about a side issue — you are talking about friction across a $3.3B revenue base.
impact: management cannot hide a trade shock inside a small business line because this page only shows one revenue engine
med
thin margins make earnings fragile
the company posted a 5.0% net margin overall, but the latest quarter came in at 2.5%. that gap is the warning. when margins get cut in half, earnings can fall much faster than revenue.
impact: another stretch of 2.5% margin quarters would make the 31.2x multiple look even more demanding
med
the specialty pivot may take longer than investors want
the thesis is that a shift away from more commodity exposure improves profitability. recent numbers went the other way: full-year EPS fell from $1.84 to $1.25 while revenue barely grew.
impact: if the mix shift stays theoretical, you are left owning a modest-return materials company priced like improvement is already coming
med
leverage limits how much disappointment the story can absorb
B+ balance sheet grade is fine. $2.0B in long-term debt, equal to 35% of capital, means it is not a balance sheet you want paired with weak earnings momentum for too long.
impact: in a softer profit environment, debt matters more because you do not have a giant margin cushion doing the work for you
a $3.3B business with a 5.0% net margin and $2.0B in long-term debt does not have much room for repeated 2.5% margin quarters.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
next earnings report
the next checkpoint on this page is $745M in sales and $0.54 in EPS. the sales number matters, but the EPS number matters more.
metric
margin recovery
watch whether quarterly margin moves off 2.5% and back toward the 5.0% net margin profile. that tells you if the mix shift is real.
risk
trade and tariff language
read the next filing and earnings call for any change in sourcing, tariffs, or cross-border demand. with a global materials business, wording changes matter.
trend
institutional flow
institutions were net sellers again in 3q2025. if that streak extends, big money is telling you it still does not buy the turnaround.
Analyst rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts think this stock is more likely to lag than lead over the next stretch.
risk profile
average
stability score 3 — this is middle-of-the-pack risk, not a bunker stock and not a rollercoaster.
chart momentum
bottom 5%
technical score 5 is the lowest rating. the tape has not been kind, and analysts are not pretending otherwise.
earnings predictability
20 / 100
earnings predictability at 20/100 means the numbers can move around more than you would like for a 31.2x stock.
source: institutional data
Institutional activity
institutions have been net selling for 2 consecutive quarters — 133 buyers vs. 178 sellers in 3q2025. total institutional holdings: 90.9M shares. net selling for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$30
$72
$39
current price
$51
target midpoint · +31% from current · 3-5yr high: $55 (+40% · 11% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive